Teriflunomide reduces relapse-related neurological sequelae, hospitalizations and steroid use.
O'Connor PW, Lublin FD, Wolinsky JS, Confavreux C, Comi G, Freedman MS, Olsson TP, Miller AE, Dive-Pouletty C, Bégo-Le-Bagousse G, Kappos L.
O'Connor PW, et al. Among authors: dive pouletty c.
J Neurol. 2013 Oct;260(10):2472-80. doi: 10.1007/s00415-013-6979-y. Epub 2013 Jul 14.
J Neurol. 2013.
PMID: 23852658
Free PMC article.
Clinical Trial.